{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:54:44Z","timestamp":1793724884442,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11064-019-02917-y","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T18:02:36Z","timestamp":1574791356000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["MicroRNAs and Child Neuropsychiatric Disorders: A Brief Review"],"prefix":"10.1007","volume":"45","author":[{"given":"Sujay","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Roxana","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsab\u00e9 S\u00e1nchez","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-1378","authenticated-orcid":false,"given":"Ashutosh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"2917_CR1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.febslet.2012.02.050","volume":"586","author":"L Wu","year":"2012","unstructured":"Wu L, Li H, Jia CY et al (2012) MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 586:1038\u20131043. https:\/\/doi.org\/10.1016\/j.febslet.2012.02.050","journal-title":"FEBS Lett"},{"key":"2917_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/jcm8010088","volume":"8","author":"A Tonacci","year":"2019","unstructured":"Tonacci A, Bagnato G, Pandolfo G et al (2019) MicroRNA cross-involvement in autism spectrum disorders and atopic dermatitis: a literature review. J Clin Med 8:88. https:\/\/doi.org\/10.3390\/jcm8010088","journal-title":"J Clin Med"},{"key":"2917_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nsmb1167","volume":"13","author":"GM Borchert","year":"2006","unstructured":"Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13:1097","journal-title":"Nat Struct Mol Biol"},{"key":"2917_CR4","volume-title":"Essentials of noncoding RNA in neuroscience: ontogenetics, plasticity of the vertebrate brain","author":"M Geaghan","year":"2017","unstructured":"Geaghan M, Cairns MJ (2017) Small RNA dysregulation in neurocognitive and neuropsychiatric disorders. In: Geaghan M, Cairns MJ (eds) Essentials of noncoding RNA in neuroscience: ontogenetics, plasticity of the vertebrate brain. Academic Press, Cambridge"},{"key":"2917_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(11)60827-1","volume":"378","author":"C Kieling","year":"2011","unstructured":"Kieling C, Baker-Henningham H, Belfer M et al (2011) Child and adolescent mental health worldwide: evidence for action. Lancet 378:1515\u20131525. https:\/\/doi.org\/10.1016\/S0140-6736(11)60827-1","journal-title":"Lancet"},{"key":"2917_CR6","volume-title":"Child psychopathology","author":"EJ Mash","year":"2014","unstructured":"Mash EJ, Barkley RA (2014) Child psychopathology. Guilford Publications, New York"},{"key":"2917_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1213\/ANE.0000000000002444","volume":"126","author":"S Kreth","year":"2018","unstructured":"Kreth S, H\u00fcbner M, Hinske LC (2018) MicroRNAs as clinical biomarkers and therapeutic tools in perioperative medicine. Anesth Analg 126:670\u2013681","journal-title":"Anesth Analg"},{"key":"2917_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fpsyt.2016.00176","volume":"7","author":"SD Hicks","year":"2016","unstructured":"Hicks SD, Middleton FA (2016) A comparative review of microRNA expression patterns in autism spectrum disorder. Front Psychiatry 7:176. https:\/\/doi.org\/10.3389\/fpsyt.2016.00176","journal-title":"Front Psychiatry"},{"key":"2917_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1097\/WNR.0000000000001107","volume":"29","author":"D Yu","year":"2018","unstructured":"Yu D, Jiao X, Cao T, Huang F (2018) Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B. NeuroReport 29:1431\u20131436. https:\/\/doi.org\/10.1097\/WNR.0000000000001107","journal-title":"NeuroReport"},{"key":"2917_CR10","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1523\/JNEUROSCI.2321-15.2016","volume":"36","author":"M Ka","year":"2016","unstructured":"Ka M, Chopra DA, Dravid SM, Kim WY (2016) Essential roles for ARID1B in dendritic arborization and spine morphology of developing pyramidal neurons. J Neurosci 36:2723\u20132742","journal-title":"J Neurosci"},{"key":"2917_CR11","doi-asserted-by":"publisher","first-page":"39663","DOI":"10.1038\/srep39663","volume":"6","author":"L Shen","year":"2016","unstructured":"Shen L, Lin Y, Sun Z et al (2016) Knowledge-guided bioinformatics model for identifying autism spectrum disorder diagnostic microRNA biomarkers. Sci Rep 6:39663. https:\/\/doi.org\/10.1038\/srep39663","journal-title":"Sci Rep"},{"key":"2917_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fneur.2014.00205","volume":"5","author":"S Banerjee-Basu","year":"2014","unstructured":"Banerjee-Basu S, Larsen E, Muend S (2014) Common microRNAs target established ASD genes. Front Neurol 5:205","journal-title":"Front Neurol"},{"key":"2917_CR13","doi-asserted-by":"publisher","first-page":"e0129052","DOI":"10.1371\/journal.pone.0129052","volume":"10","author":"F Huang","year":"2015","unstructured":"Huang F, Long Z, Chen Z et al (2015) Investigation of gene regulatory networks associated with autism spectrum disorder based on MiRNA expression in China. PLoS ONE 10:e0129052. https:\/\/doi.org\/10.1371\/journal.pone.0129052","journal-title":"PLoS ONE"},{"key":"2917_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.75","author":"PM Martin","year":"2013","unstructured":"Martin PM, Yang X, Robin N et al (2013) A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation. Transl Psychiatry. https:\/\/doi.org\/10.1038\/tp.2013.75","journal-title":"Transl Psychiatry"},{"key":"2917_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2040-2392-5-40","volume":"5","author":"M Vasu","year":"2014","unstructured":"Vasu M, Anitha A, Thanseem I et al (2014) Serum microRNA profiles in children with autism. Mol Autism 5:40. https:\/\/doi.org\/10.1186\/2040-2392-5-40","journal-title":"Mol Autism"},{"key":"2917_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/folmed-2017-0009","volume":"59","author":"TM Kichukova","year":"2017","unstructured":"Kichukova TM, Popov NT, Ivanov IS, Vachev TI (2017) Profiling of circulating serum microRNAs in children with autism spectrum disorder using stem-loop qRT-PCR assay. Folia Med 59:43\u201352. https:\/\/doi.org\/10.1515\/folmed-2017-0009","journal-title":"Folia Med"},{"key":"2917_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-015-0064-6","volume":"7","author":"LS Nguyen","year":"2016","unstructured":"Nguyen LS, Lepleux M, Makhlouf M et al (2016) Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology. Mol Autism 7:1. https:\/\/doi.org\/10.1186\/s13229-015-0064-6","journal-title":"Mol Autism"},{"key":"2917_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13229-015-0029-9","volume":"6","author":"BP Ander","year":"2015","unstructured":"Ander BP, Barger N, Stamova B et al (2015) Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders. Mol Autism 6:37. https:\/\/doi.org\/10.1186\/s13229-015-0029-9","journal-title":"Mol Autism"},{"key":"2917_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnsyn.2019.00002","volume":"11","author":"C Danesi","year":"2019","unstructured":"Danesi C, Kein\u00e4nen K, Castr\u00e9n ML (2019) Dysregulated Ca2+-permeable AMPA receptor signaling in neural progenitors modeling fragile X syndrome. Front Synaptic Neurosci 11:2","journal-title":"Front Synaptic Neurosci"},{"key":"2917_CR20","first-page":"384","volume":"2","author":"T Vachev","year":"2013","unstructured":"Vachev T, Minkov I, Stoyanova V, Popov N (2013) Down regulation of miRNA let-7b-3p and let-7d-3p in the peripheral blood of children with autism spectrum disorder. Int J Curr Microbiol Appl Sci 2:384\u2013388","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"2917_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12402-017-0232-y","volume":"10","author":"S Srivastav","year":"2018","unstructured":"Srivastav S, Walitza S, Gr\u00fcnblatt E (2018) Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review. ADHD Atten Deficit Hyperact Disord 10:49\u201363. https:\/\/doi.org\/10.1007\/s12402-017-0232-y","journal-title":"ADHD Atten Deficit Hyperact Disord"},{"key":"2917_CR22","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1750-3639.2010.00410.x","volume":"20","author":"L Wu","year":"2010","unstructured":"Wu L, Zhao Q, Zhu X et al (2010) A novel function of microRNA Let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain. Brain Pathol 20:1042\u20131054. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00410.x","journal-title":"Brain Pathol"},{"key":"2917_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12017-015-8345-y","volume":"17","author":"LH Wu","year":"2015","unstructured":"Wu LH, Peng M, Yu M et al (2015) Circulating microRNA Let-7d in attention-deficit\/hyperactivity disorder. Neuromol Med 17:137\u2013146. https:\/\/doi.org\/10.1007\/s12017-015-8345-y","journal-title":"Neuromol Med"},{"key":"2917_CR24","doi-asserted-by":"publisher","first-page":"S887","DOI":"10.1016\/j.euroneuro.2017.08.191","volume":"29","author":"C S\u00e1nchez-Mora","year":"2019","unstructured":"S\u00e1nchez-Mora C, Garcia-Mart\u00c3nez I, Pagerols M et al (2019) Correlation analysis of miRNA and mRNA expression profiles in peripheral blood mononuclear cells from ADHD patients and controls. Eur Neuropsychopharmacol 29:S887. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.08.191","journal-title":"Eur Neuropsychopharmacol"},{"key":"2917_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jpsychires.2018.12.013","volume":"109","author":"F Zadehbagheri","year":"2019","unstructured":"Zadehbagheri F, Hosseini E, Bagheri-Hosseinabadi Z et al (2019) Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations. J Psychiatr Res 109:185\u2013192. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.12.013","journal-title":"J Psychiatr Res"},{"key":"2917_CR26","doi-asserted-by":"publisher","first-page":"e84207","DOI":"10.1371\/journal.pone.0084207","volume":"8","author":"N Nemeth","year":"2013","unstructured":"Nemeth N, Kov\u00e1cs-Nagy R, Sz\u00e9kely A et al (2013) Association of impulsivity and polymorphic microRNA-641 target sites in the SNAP-25 gene. PLoS ONE 8:e84207. https:\/\/doi.org\/10.1371\/journal.pone.0084207","journal-title":"PLoS ONE"},{"key":"2917_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.euroneuro.2013.07.002","volume":"23","author":"C S\u00e1nchez-Mora","year":"2013","unstructured":"S\u00e1nchez-Mora C, Ramos-Quiroga JA, Garcia-Mart\u00ednez I et al (2013) Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs). Eur Neuropsychopharmacol 23:1463\u20131473. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.07.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"2917_CR28","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1038\/tp.2016.151","volume":"6","author":"I Garcia-Mart\u00ednez","year":"2016","unstructured":"Garcia-Mart\u00ednez I, S\u00e1nchez-Mora C, Pagerols M et al (2016) Preliminary evidence for association of genetic variants in pri-miR-34b\/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder. Transl Psychiatry 6:e879. https:\/\/doi.org\/10.1038\/tp.2016.151","journal-title":"Transl Psychiatry"},{"key":"2917_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jocn.2014.08.018","volume":"22","author":"XY Sun","year":"2015","unstructured":"Sun XY, Lu J, Zhang L et al (2015) Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. J Clin Neurosci 22:570\u2013574","journal-title":"J Clin Neurosci"},{"key":"2917_CR30","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1038\/tp.2015.213","volume":"6","author":"CY Lai","year":"2016","unstructured":"Lai CY, Lee SY, Scarr E et al (2016) Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. Transl Psychiatry 6:e717","journal-title":"Transl Psychiatry"},{"key":"2917_CR31","doi-asserted-by":"publisher","first-page":"e873","DOI":"10.1371\/journal.pone.0000873","volume":"2","author":"T Hansen","year":"2007","unstructured":"Hansen T, Olsen L, Lindow M et al (2007) Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873. https:\/\/doi.org\/10.1371\/journal.pone.0000873","journal-title":"PLoS ONE"},{"key":"2917_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.biopsych.2008.11.019","volume":"65","author":"N Mellios","year":"2009","unstructured":"Mellios N, Huang HS, Baker SP et al (2009) Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65:1006\u20131014. https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.019","journal-title":"Biol Psychiatry"},{"key":"2917_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/schbul\/sbq091","volume":"38","author":"N Mellios","year":"2012","unstructured":"Mellios N, Galdzicka M, Ginns E et al (2012) Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull 38:433\u2013443. https:\/\/doi.org\/10.1093\/schbul\/sbq091","journal-title":"Schizophr Bull"},{"key":"2917_CR34","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/stem.431","volume":"28","author":"RD Smrt","year":"2010","unstructured":"Smrt RD, Szulwach KE, Pfeiffer RL et al (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28:1060\u20131070. https:\/\/doi.org\/10.1002\/stem.431","journal-title":"Stem Cells"},{"key":"2917_CR35","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/hmg\/ddn005","volume":"17","author":"NJ Beveridge","year":"2008","unstructured":"Beveridge NJ, Tooney PA, Carroll AP et al (2008) Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 17:1156\u20131168. https:\/\/doi.org\/10.1093\/hmg\/ddn005","journal-title":"Hum Mol Genet"},{"key":"2917_CR36","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mp.2009.84","volume":"15","author":"NJ Beveridge","year":"2010","unstructured":"Beveridge NJ, Gardiner E, Carroll AP et al (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 15:1176. https:\/\/doi.org\/10.1038\/mp.2009.84","journal-title":"Mol Psychiatry"},{"key":"2917_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/schbul\/sbv139","volume":"42","author":"S Kimoto","year":"2016","unstructured":"Kimoto S, Glausier JR, Fish KN et al (2016) Reciprocal alterations in regulator of g protein signaling 4 and micro RNA16 in Schizophrenia. Schizophr Bull 42:396\u2013405","journal-title":"Schizophr Bull"},{"key":"2917_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neulet.2010.11.040","volume":"488","author":"K Hu","year":"2011","unstructured":"Hu K, Zhang C, Long L et al (2011) Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 488:252\u2013257. https:\/\/doi.org\/10.1016\/j.neulet.2010.11.040","journal-title":"Neurosci Lett"},{"key":"2917_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2011.09.039","volume":"1424","author":"RM Risbud","year":"2011","unstructured":"Risbud RM, Lee C, Porter BE (2011) Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus. Brain Res 1424:53\u201359. https:\/\/doi.org\/10.1016\/j.brainres.2011.09.039","journal-title":"Brain Res"},{"key":"2917_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12031-013-9953-3","volume":"50","author":"J Peng","year":"2013","unstructured":"Peng J, Omran A, Ashhab MU et al (2013) Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy. J Mol Neurosci 50:291\u2013297. https:\/\/doi.org\/10.1007\/s12031-013-9953-3","journal-title":"J Mol Neurosci"},{"key":"2917_CR41","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/S1474-4422(16)30246-0","volume":"15","author":"DC Henshall","year":"2016","unstructured":"Henshall DC, Hamer HM, Pasterkamp RJ et al (2016) MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol 15:1368\u20131376. https:\/\/doi.org\/10.1016\/S1474-4422(16)30246-0","journal-title":"Lancet Neurol"},{"key":"2917_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/wcs.1383","volume":"7","author":"O Ozernov-Palchik","year":"2016","unstructured":"Ozernov-Palchik O, Gaab N (2016) Tackling the \u201cdyslexia paradox\u201d: reading brain and behavior for early markers of developmental dyslexia. Wiley Interdiscip Rev Cogn Sci 7:156\u2013176. https:\/\/doi.org\/10.1002\/wcs.1383","journal-title":"Wiley Interdiscip Rev Cogn Sci"},{"key":"2917_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/dys.1464","volume":"19","author":"A Carrion-Castillo","year":"2013","unstructured":"Carrion-Castillo A, Franke B, Fisher SE (2013) Molecular genetics of dyslexia: an overview. Dyslexia 19:214\u2013240. https:\/\/doi.org\/10.1002\/dys.1464","journal-title":"Dyslexia"},{"key":"2917_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4161\/epi.26026","volume":"8","author":"A Rudov","year":"2013","unstructured":"Rudov A, Rocchi MBL, Accorsi A et al (2013) Putative miRNAs for the diagnosis of dyslexia, dyspraxia, and specific language impairment. Epigenetics 8:1023\u20131029. https:\/\/doi.org\/10.4161\/epi.26026","journal-title":"Epigenetics"},{"key":"2917_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/mp.2010.105","volume":"16","author":"G Poelmans","year":"2011","unstructured":"Poelmans G, Buitelaar JK, Pauls DL, Franke B (2011) A theoretical molecular network for dyslexia: integrating available genetic findings. Mol Psychiatry 16:365","journal-title":"Mol Psychiatry"},{"key":"2917_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-015-0133-y","volume":"8","author":"R Rizzo","year":"2015","unstructured":"Rizzo R, Ragusa M, Barbagallo C et al (2015) Circulating miRNAs profiles in tourette syndrome: molecular data and clinical implications. Mol Brain 8:44. https:\/\/doi.org\/10.1186\/s13041-015-0133-y","journal-title":"Mol Brain"},{"key":"2917_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/mp.2011.151","volume":"17","author":"I Karagiannidis","year":"2012","unstructured":"Karagiannidis I, Rizzo R, Tarnok Z et al (2012) Replication of association between a SLITRK1 haplotype and Tourette syndrome in a large sample of families. Mol Psychiatry 17:665. https:\/\/doi.org\/10.1038\/mp.2011.151","journal-title":"Mol Psychiatry"},{"key":"2917_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1126\/science.1116502","volume":"310","author":"JF Abelson","year":"2005","unstructured":"Abelson JF, Kwan KY, O\u2019Roak BJ et al (2005) Medicine: sequence variants in SLITRK1 are associated with Tourette\u2019s syndrome. Science 310:317\u2013320. https:\/\/doi.org\/10.1126\/science.1116502","journal-title":"Science"},{"key":"2917_CR49","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161","journal-title":"Nat Neurosci"},{"key":"2917_CR50","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.2174\/1381612820666140314151924","volume":"20","author":"D Greenberg","year":"2014","unstructured":"Greenberg D, Soreq H (2014) MicroRNA therapeutics in neurological disease. Curr Pharm Des 20:6022\u20136027","journal-title":"Curr Pharm Des"},{"key":"2917_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnmol.2019.00031","volume":"12","author":"P Bielefeld","year":"2019","unstructured":"Bielefeld P, Schouten M, Meijer GM et al (2019) Co-administration of anti microRNA-124 and -137 oligonucleotides prevents hippocampal neural stem cell loss upon non-convulsive seizures. Front Mol Neurosci 12:31","journal-title":"Front Mol Neurosci"},{"key":"2917_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.omtn.2016.11.002","volume":"6","author":"CR Reschke","year":"2017","unstructured":"Reschke CR, Silva LFA, Norwood BA et al (2017) Potent anti-seizure effects of locked nucleic acid antagomirs targeting miR-134 in multiple mouse and rat models of epilepsy. Mol Ther Nucleic Acids 6:45\u201356","journal-title":"Mol Ther Nucleic Acids"},{"key":"2917_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphar.2016.00129","volume":"7","author":"Z Cai","year":"2016","unstructured":"Cai Z, Li S, Li S et al (2016) Antagonist targeting microRNA-155 protects against lithium-pilocarpine-induced status epilepticus in C57BL\/6 mice by activating brain-derived neurotrophic factor. Front Pharmacol 7:129","journal-title":"Front Pharmacol"},{"key":"2917_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-014-8981-5","volume":"53","author":"H Zheng","year":"2016","unstructured":"Zheng H, Tang R, Yao Y et al (2016) MiR-219 protects against seizure in the kainic acid model of epilepsy. Mol Neurobiol 53:1\u20137","journal-title":"Mol Neurobiol"},{"key":"2917_CR55","first-page":"5356","volume":"17","author":"H Zhang","year":"2018","unstructured":"Zhang H, Qu Y, Wang A (2018) Antagonist targeting microRNA-146a protects against lithium-pilocarpine-induced status epilepticus in rats by nuclear factor-\u03baB pathway. Mol Med Rep 17:5356\u20135361","journal-title":"Mol Med Rep"},{"key":"2917_CR56","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1007\/s00018-016-2179-0","volume":"73","author":"A Kos","year":"2016","unstructured":"Kos A, Olde Loohuis N, Meinhardt J et al (2016) MicroRNA-181 promotes synaptogenesis and attenuates axonal outgrowth in cortical neurons. Cell Mol Life Sci 73:3555\u20133567","journal-title":"Cell Mol Life Sci"},{"key":"2917_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","volume":"12","author":"H Uwatoko","year":"2019","unstructured":"Uwatoko H, Hama Y, Iwata IT et al (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12:49","journal-title":"Mol Brain"},{"key":"2917_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1073858402239590","volume":"9","author":"EM Talley","year":"2003","unstructured":"Talley EM, Sirois JE, Lei Q, Bayliss DA (2003) Two-pore-domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist 9:46\u201356","journal-title":"Neuroscientist"},{"key":"2917_CR59","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3233\/JAD-150395","volume":"48","author":"HK Karnati","year":"2015","unstructured":"Karnati HK, Panigrahi MK, Gutti RK et al (2015) miRNAs: key players in neurodegenerative disorders and epilepsy. J Alzheimer\u2019s Dis 48:563\u2013580","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2917_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s13238-016-0272-7","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Chen M, Qiu Z et al (2016) MiR-130a regulates neurite outgrowth and dendritic spine density by targeting MeCP2. Protein Cell 7:489\u2013500","journal-title":"Protein Cell"},{"key":"2917_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12993-015-0066-8","volume":"11","author":"O \u0160er\u00fd","year":"2015","unstructured":"\u0160er\u00fd O, Paclt I, Drt\u00edlkov\u00e1 I et al (2015) A 40-bp VNTR polymorphism in the 3\u2032-untranslated region of DAT1\/SLC6A3 is associated with ADHD but not with alcoholism. Behav Brain Funct 11:21","journal-title":"Behav Brain Funct"},{"key":"2917_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41065-017-0044-2","volume":"155","author":"K He","year":"2018","unstructured":"He K, Guo C, He L, Shi Y (2018) miRNAs of peripheral blood as the biomarker of schizophrenia. Hereditas 155:9","journal-title":"Hereditas"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02917-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:51:39Z","timestamp":1606251099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02917-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2917"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02917-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"17 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}